The prognostic indicator in breast cancer treated with CDK4/6 inhibitors: the prognostic nutritional index

References

• Siegel RL , MillerKD, JemalA. Cancer statistics, 2019. CA Cancer J. Clin.69, 7–34 (2019).
   PubMed Web of Science ®Google Scholar
• DeSantis CE , LinCC, MariottoABet al. Cancer treatment and survivorship statistics, 2014. CA Cancer J. Clin.64(4), 252–271 (2014).
   PubMed Web of Science ®Google Scholar
• Emens LA . Breast cancer immunotherapy: facts and hopes. Clin. Cancer Res.24, 511–520 (2018).
   PubMed Web of Science ®Google Scholar
• Nagini S . Breast cancer: current molecular therapeutic targets and new players. Anticancer Agents Med. Chem.17, 152–163 (2017).
   PubMed Web of Science ®Google Scholar
• Anderson WF , ChatterjeeN, ErshlerWB, BrawleyOW. Estrogen receptor breast cancer phenotypes in the Surveillance, Epidemiology, and End Results database. Breast Cancer Res. Treat.76, 27–36 (2002).
   PubMed Web of Science ®Google Scholar
• Yue W , YagerJD, WangJP, JupeER, SantenRJ. Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis. Steroids78, 161–170 (2013).
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network . NCCN Clinical Practice Guidelines in Oncology: Breast Cancer v3.2020 (2020). www.nccn.org/professionals/physician_gls/pdf/breast_blocks.pdf
   Google Scholar
• Files JA , KoMG, PruthiS. Managing aromatase inhibitors in breast cancer survivors: not just for oncologists. Mayo Clin. Proc.85, 560–566 (2010).
   PubMed Web of Science ®Google Scholar
• Nagaraj G , MaCX. Clinical challenges in the management of hormone receptor-positive, human epidermal growth factor receptor 2-negative metastatic breast cancer: a literature review. Adv. Ther.38, 109–136 (2021).
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration . Palbociclib highlights of prescribing information (2018). www.accessdata.fda.gov/drugsatfda_docs/label/2018/207103s007lbl.pdf
   Google Scholar
• US Food and Drug Administration . Ribociclib highlights of prescribing information (2018). www.accessdata.fda.gov/drugsatfda_docs/label/2018/209092s001lbl.pdf
   Google Scholar
• US Food and Drug Administration . Abemaciclib highlights of prescribing information (2018). www.accessdata.fda.gov/drugsatfda_docs/label/2018/208855s000lbl.pdf
   Google Scholar
• Sarhill N , MahmoudFA, ChristieR, TahirA. Assessment of nutritional status and fluid deficits in advanced cancer. Am. J. Hosp. Palliat. Care20, 465–473 (2003).
   PubMedGoogle Scholar
• Arends J , BodokyG, BozzettiFet al. ESPEN guidelines on enteral nutrition: non-surgical oncology. Clin. Nutr.25, 245–259 (2006).
   PubMed Web of Science ®Google Scholar
• Scott HR , ForrestLM, BrownDJF, McArdleCS, MilroyR. The systemic inflammatory response, weight loss, performance status and survival in patients with inoperable non-small-cell lung cancer. Br. J. Cancer87, 264–267 (2002).
   PubMed Web of Science ®Google Scholar
• Zitvogel L , PietrocolaF, KroemerG. Nutrition, inflammation and cancer. Nat. Immunol.18, 843–850 (2017).
   PubMed Web of Science ®Google Scholar
• Gupta D , LisCG. Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature. Nutr. J.9, 69 (2017).
   Google Scholar
• Mahmoud SM , PaishEC, PoweDG, MacmillanRD, GraingeMJ, LeeAHet al. Tumor-infiltrating CD8+ lymphocytes predict clinical outcome in breast cancer. J. Clin. Oncol.29, 1949–1955 (2011).
   PubMed Web of Science ®Google Scholar
• Carney DE , MeguidMM. Current concepts in nutritional assessment. Arch. Surg.137, 42–45 (2002).
   PubMedGoogle Scholar
• Waitzberg DL , CorreiaMI. Nutritional assessment in the hospitalized patient. Curr. Opin. Clin. Nutr. Metab. Care6, 531–538 (2003).
   PubMed Web of Science ®Google Scholar
• Detsky AS , BakerJP, MendelsonRA, WolmanSL, WessonDE, JeejeebhoyKN. Evaluating the accuracy of nutritional assessment techniques applied to hospitalized patients: methodology and comparisons. JPEN J. Parenter. Enteral Nutr.8, 153–159 (1984).
   PubMed Web of Science ®Google Scholar
• Bauer J , CapraS, FergusonM. Use of the scored Patient-Generated Subjective Global Assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur. J. Clin. Nutr.56, 779–785 (2002).
   PubMed Web of Science ®Google Scholar
• Gupta D , LammersfeldCA, VashiPGet al. Bioelectrical impedance phase angle as a prognostic indicator in breast cancer. BMC Cancer8, 249 (2008).
   PubMed Web of Science ®Google Scholar
• Albano D , MessinaC, VitaleJ, SconfienzaLM. Imaging of sarcopenia: old evidentity and new insights. Eur. Radiol.30(4), 2199–2208 (2020).
   PubMed Web of Science ®Google Scholar
• Onodera T , GosekiN, KosakiG. Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients. Nihon Geka Gakkai Zasshi85, 1001–1005 (1984).
   PubMedGoogle Scholar
• Yang Y , GaoP, SongYet al. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: a meta-analysis. Eur. J. Surg. Oncol.42, 1176–1182 (2016).
   PubMed Web of Science ®Google Scholar
• Yang Y , GaoP, ChenXet al. Prognostic significance of preoperative prognostic nutritional index in colorectal cancer: results from a retrospective cohort study and a meta-analysis. Oncotarget7, 58543–58552 (2016).
   PubMedGoogle Scholar
• Shoji F , MorodomiY, AkamineTet al. Predictive impact for postoperative recurrence using the preoperative prognostic nutritional index in pathological stage I non-small cell lung cancer. Lung Cancer98, 15–21 (2016).
   PubMed Web of Science ®Google Scholar
• Qiu C , QuX, ShenHet al. Evaluation of prognostic nutritional index in patients undergoing radical surgery with nonsmall cell lung cancer. Nutr. Cancer67, 741–747 (2015).
   PubMed Web of Science ®Google Scholar
• Mori S , UsamiN, FukumotoKet al. The significance of the prognostic nutritional index in patients with completely resected non-small cell lung cancer. PLOS ONE10, e0136897 (2015).
   PubMed Web of Science ®Google Scholar
• Kanda M , FujiiT, KoderaY, NagaiS, TakedaS, NakaoA. Nutritional predictors of postoperative outcome in pancreatic cancer. Br. J. Surg.98, 268–274 (2011).
   PubMed Web of Science ®Google Scholar
• Broggi MS , PatilD, BaumYet al. Onodera’s prognostic nutritional index as an independent prognostic factor in clear cell renal cell carcinoma. Urology96, 99–105 (2016).
   PubMedGoogle Scholar
• Nakatani M , MigitaK, MatsumotoSet al. Prognostic significance of the prognostic nutritional index in esophageal cancer patients undergoing neoadjuvant chemotherapy. Dis. Esophagus30, 1–7 (2017).
   PubMed Web of Science ®Google Scholar
• Pinato DJ , NorthBV, SharmaR. A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI). Br. J. Cancer106, 1439–1445 (2012).
   PubMed Web of Science ®Google Scholar
• Sun J , WangD, MeiYet al. Value of the prognostic nutritional index in advanced gastric cancer treated with preoperative chemotherapy. J. Surg. Res.209, 37–44 (2017).
   PubMed Web of Science ®Google Scholar
• Chen L , BaiP, KongXet al. Prognostic nutritional index (PNI) in patients with breast cancer treated with neoadjuvant chemotherapy as a useful prognostic indicator. Front. Cell Dev. Biol.9, 656741 (2021).
   PubMed Web of Science ®Google Scholar
• Mohri T , MohriY, ShigemoriTet al. Impact of prognostic nutritional index on long-term outcomes in patients with breast cancer. World J. Surg. Oncol.14, 170 (2016).
   PubMed Web of Science ®Google Scholar
• Wang Y , BattserenB, YinWet al. Predictive and prognostic value of prognostic nutritional index for locally advanced breast cancer. Gland Surg.8(6), 618–626 (2019).
   PubMed Web of Science ®Google Scholar
• Abdel-Rahman O . Validation of the 8th AJCC prognostic staging system for breast cancer in a population-based setting. Breast Cancer Res. Treat.168(1), 269–275 (2018).
   PubMed Web of Science ®Google Scholar
• Eisenhauer EA , TherasseP, BogaertsJet al. New response evaluation criteria in solid tumors: revised RECIST guideline (version 1.1). Eur. J. Cancer45, 228–247 (2019).
   Google Scholar
• US Department of Health and Human Services . Common Terminology Criteria for Adverse Events, v. 5.0 (2017). https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_8.5x11.pdf
   Google Scholar
• Weiss G . Nutrition and infection. Clin. Microbiol. Infect.24, 8–9 (2018).
   PubMed Web of Science ®Google Scholar
• Shen Q , LiuW, QuanHet al. Prealbumin and lymphocyte-based prognostic score, a new tool for predicting long-term survival after curative resection of stage II/III gastric cancer. Br. J. Nutr.120, 1359–1369 (2018).
   PubMed Web of Science ®Google Scholar
• Grace EM , ShawC, LaljiA, MohammedK, AndreyevHJN, WhelanK. Nutritional status, the development and persistence of malnutrition and dietary intake in oesophago-gastric cancer: a longitudinal cohort study. J. Hum. Nutr. Diet.31, 785–792 (2018).
   PubMed Web of Science ®Google Scholar
• Lyu J , LiT, XieCet al. Enteral nutrition in esophageal cancer patients treated with radiotherapy: a Chinese expert consensus. Future Oncol.15, 517–531 (2018).
   PubMed Web of Science ®Google Scholar
• Hua X , LongZ-Q, HuangXet al. The value of prognostic nutritional index (PNI) in predicting survival and guiding radiotherapy of patients with T1–2N1 breast cancer. Front. Oncol.9, 1562 (2020).
   PubMed Web of Science ®Google Scholar
• Oba T , MaenoK, TakekoshiDet al. Neoadjuvant chemotherapy-induced decrease of prognostic nutrition index predicts poor prognosis in patients with breast cancer. BMC Cancer20, 160 (2020).
   PubMed Web of Science ®Google Scholar
• Hiura Y , TakiguchiS, YamamotoKet al. Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: a prospective, randomized, placebo-controlled phase 2 study. Cancer118, 4785–4794 (2012).
   PubMed Web of Science ®Google Scholar
• Peuker CA , YaghobramziS, GrunertCet al. Treatment with ribociclib shows favorable immunomodulatory effects in patients with hormone receptor-positive breast cancer-findings from the RIBECCA trial. Eur. J. Cancer162, 45–55 (2022).
   PubMed Web of Science ®Google Scholar